Session Details
[1O06a]Neurological disorders
Mon. Mar 17, 2025 1:40 PM - 3:30 PM JST
Mon. Mar 17, 2025 4:40 AM - 6:30 AM UTC
Mon. Mar 17, 2025 4:40 AM - 6:30 AM UTC
Room 6
Oranizers : Hideki Hayashi (School of Pharmacy, Department of Applied Biochemistry, Tokyo University of Pharmacy and Life Sciences) and Akihiro Mouri (Department of Regulatory Science, Fujita Health University Graduate School of Medical Sciences.)
[1O06a-01（ST06-08）]Involvement of noradrenaline transmission-mediated activation of the anterior cingulate cortex in psychosocial stress-induced enhancement of cocaine craving
○Atsushi Saito1, Yuno Mukai1, Junpei Nagasaki2, Haruki Sakaguchi2, Xiyan Ni1, Haruka Murata2, Naoya Nishitani1,2, Satoshi Deyama1,2, Katsuyuki Kaneda1,2 (1.Lab. Mol. Pharmacol., Inst. Med., Pharmaceut., Health Sci., Kanazawa Univ., 2.Lab. Mol. Pharmacol., Sch. Pharmaceut. Sci., Kanazawa Univ.)
[1O06a-02（ST05-11）]Effects of nasal treatment with high mobility group box-1 neutralizing antibody on hippocampal neuroinflammation in mice with neuropathic pain
○Koji Tagami1, Kazue Nakashima1, Yoki Nakamura1, Masahiro Nishibori2, Norimitsu Morioka1 (1.Dept. Pharmacol., Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2.Dept. Transl. Res. Drug Dev., Grad. Sch. Med. Dent. Pharmaceut. Sci., Okayama Univ.)
[1O06a-03]Unveiling the role of vascular endothelial growth factor signaling in a mouse model of cerebral ischemia
○Mika Takarada-Iemata, Nahoko Okitani, Osamu Hori (Dept. Neuroanat., Kanazawa Univ.)
[1O06a-04（ST06-05）]Pathological role of Fatty Acid-Binding Protein 2 (FABP2) in α-Synuclein pathology of enteric neurons
○Tomoki Sekimori1, Kohji Fukunaga2, Takuya Sasaki1,3, Ichiro Kawahata4 (1.Dept. Pharmacol., Grad. Sch. Pharmaceut. Sci., Tohoku Univ., 2.BRI Pharma Inc., 3.Dept. Neuropharmacol., Grad. Sch. Med., Tohoku Univ., 4.Dept. Mol. Genet., Sch. Med., Fukushima Med. Univ.)
[1O06a-05]A cellulose-rich diet disrupts gut homeostasis and leads to anxiety through the gut-brain axis
○Chihiro Nozaki1, Kaede Ito2, Haruka Hosoki2, Yuya Kasai2, Hiroyuki Sasaki2, Atsushi Haraguchi2, Shigenobu Shibata3 (1.Waseda University, Global Center for Science and Engineering, 2.Waseda University, Graduate School of Advanced Science and Engineering, 3.Hiroshima University, Graduate School of Biomedical and Health Sciences)
[1O06a-06]Evaluation of 5xFAD mice focusing on expression level of drebrin and its metabolites
○Noriko Koganezawa1,2, Ayaka Higa2, Reiko T. Roppongi3, Sachiko Hijiki3, Tomoaki Shirao2,3, Yuko Sekino2,4,5 (1.Grad. Sch. Front. Sci., Univ. of Tokyo, 2.AlzMed, Inc., 3.Gunma Univ. Grad. Sch. Med., 4.Inst. for Drug Discov. Innov., 5.Grad. Sch. Agri. & Life Sci., Univ. of Tokyo)
[1O06a-07]Ex-vivo analysis model of early pathology of Alzheimer's disease
○Yuji Kamikubo, Xuhui Pang, Luo Lu, Yiyao Zhou, Takashi Sakurai (Juntendo University)
[1O06a-08]In vivo assessment of progressive astrogliosis in rTg4510 tauopathy animal brains
○Masafumi Shimojo1, Takeharu Minamihisamatsu1, Takahiro Shimizu1, Shoko Uchida1, Hiroshi Mizuma1, Manami Takahashi3, Hiroyuki Takuwa3, Yumi Matsushita1, Rin Yanai1, Ming-Rong Zhang2, Naruhiko Sahara1, Makoto Higuchi1 (1.Advanced Neuroimaging Center, National Institutes for Quantum Science and Technology, 2.Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology, 3.Institute for Quantum Life Science)
[1O06a-09（ST05-07）]Ceramide metabolic enzyme deficiency alleviates neuroinflammation and depressive-like behavior
○Rikuki Yoshitsugu, Uzu Miaki, Nakamura Hiroyuki (Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University)